Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.86B.
ENTERPRISE VALUE (EV)
$1.86B
BioLife Solutions, Inc.
Market Cap
$1.89B
Enterprise Value (EV)
$1.86B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | $1.86B |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | $1.80B |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | $2.40B |
| Absci Corporation (ABSI)vs › | $1.95B | $1.85B |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | $2.15B |
| Azenta, Inc. (AZTA)vs › | $1.97B | $1.83B |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | $1.71B |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | $1.75B |
| AxoGen, Inc. (AXGN)vs › | $2.00B | $1.93B |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | $2.96B |
Market Cap
$1.89B
Total Debt
$5.00M
Cash
$33.04M
Enterprise Value
$1.86B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
